Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27330769)

Published in Mol Clin Oncol on May 09, 2016

Authors

Shinsuke Tasaki1, Akio Horiguchi2, Takako Asano2, Kenji Kuroda2, Akinori Sato2, Junichi Asakuma2, Keiichi Ito2, Tomohiko Asano2, Hirotaka Asakura3

Author Affiliations

1: Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan; Department of Urology, Saitama Medical University, Iruma, Saitama 350-0495, Japan.
2: Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
3: Department of Urology, Saitama Medical University, Iruma, Saitama 350-0495, Japan.

Articles cited by this

Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74

2004 WHO classification of the renal tumors of the adults. Eur Urol (2006) 4.85

Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr (2004) 3.01

Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A (2013) 1.66

A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci (2004) 1.44

Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr (2003) 1.43

The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer (2009) 1.38

Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. J Urol (2011) 1.36

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer (2009) 1.19

Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. Cancer (2009) 1.16

Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan Public Health Center-based prospective study. Int J Cancer (2011) 1.08

Marine fatty acid intake is associated with breast cancer prognosis. J Nutr (2010) 1.07

Marine polyunsaturated fatty acids and cancer therapy. Br J Cancer (2013) 1.06

Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis (2010) 1.04

Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr (2002) 1.03

Fish oil prevents breast cancer cell metastasis to bone. Biochem Biophys Res Commun (2010) 1.01

Determination of fatty acids in the main lipoprotein classes by capillary gas chromatography: BF3/methanol transesterification of lyophilized samples instead of Folch extraction gives higher yields. Anal Biochem (1991) 1.00

Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma. Ann Hematol (2010) 0.95

The science behind dietary omega-3 fatty acids. CMAJ (2008) 0.94

Evidence and mechanisms of fat depletion in cancer. Nutrients (2014) 0.93

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo. Int J Cancer (2010) 0.90

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma. Br J Cancer (2012) 0.88

Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. Nutr Cancer (2012) 0.87

DHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and β-catenin nuclear translocation. Carcinogenesis (2011) 0.86

Articles by these authors

Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Cancer Res (2003) 1.00

Impact of increased erythropoietin receptor expression and elevated serum erythropoietin levels on clinicopathological features and prognosis in renal cell carcinoma. Exp Ther Med (2012) 0.82

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma. Oncol Lett (2014) 0.78

Bortezomib and belinostat inhibit renal cancer growth synergistically by causing ubiquitinated protein accumulation and endoplasmic reticulum stress. Biomed Rep (2015) 0.77

Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth. Mol Clin Oncol (2014) 0.77

Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report. Oncol Lett (2014) 0.75

Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy. Mol Clin Oncol (2016) 0.75

Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer. Mol Clin Oncol (2020) 0.75

Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer. Oncol Lett (2017) 0.75

Docosahexaenoic acid inhibits the phosphorylation of STAT3 and the growth and invasion of renal cancer cells. Exp Ther Med (2017) 0.75